Senior insider sale
President, R&D at TAKEDA PHARMACEUTICAL CO LTD — senior position signals high conviction
$3.00M
179.24K shares
What this filing means
PLUMP ANDREW STEWART plans to sell 179.24K shares of TAKEDA PHARMACEUTICAL CO LTD valued at approximately $3.00M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/13/2026ACC: 0001395064-26-000303
DirectorOfficer· President, R&D
Since Mar 2026
179.24K
Shares to sell
$3.00M
Approx. market value
358.73K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Unit Awards - Vested.
Compensation
7/1/2026
358.73KTotal acquired358.73K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/1/2026 | Restricted Stock Unit Awards - Vested. Compensation | 358.73K | — |
| Total | 358.73K | ||
Planned & Completed Dispositions1
NYSEPlanned
Units to sell
179.24K
Market value
$3.00M
7/13/2026
Total
Units
179.24K
Value
$3.00M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
7/13/2026 | 179.24K | $3.00M | NYSE | Planned |
| Total | 179.24K | $3.00M | ||